Efficient and Scalable Enantioselective Synthesis of a CGRP Antagonist

被引:22
|
作者
Leahy, David K. [1 ]
Fan, Yu [1 ]
Desai, Lopa V. [1 ]
Chan, Collin [1 ]
Zhu, Jason [1 ]
Luo, Guanglin [3 ]
Chen, Ling [3 ]
Hanson, Ronald L. [1 ]
Sugiyama, Masano [1 ]
Rosner, Thorsten [1 ]
Cuniere, Nicolas [1 ]
Guo, Zhiwei [1 ]
Hsiao, Yi [1 ]
Gao, Qi [2 ]
机构
[1] Bristol Myers Squibb Co, Chem Dev, New Brunswick, NJ 08903 USA
[2] Bristol Myers Squibb Co, Drug Prod Sci & Technol, New Brunswick, NJ 08903 USA
[3] Bristol Myers Squibb Co, Mol Sci & Candidate Optimizat, Wallingford, CT 06492 USA
关键词
RECEPTOR ANTAGONIST; MIGRAINE; REDUCTION; ARYLATION; CATALYSTS; HEADACHE; KETONES; HUMANS;
D O I
10.1021/ol302262q
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
An enantioselective synthesis of the CGRP antagonist BMS-846372, amenable to large scale preparation, is presented. This new synthesis showcases a chemo- and enantioselective reduction of a cyclohepta[b]pyridine-5,9-dione as well as a Pd-catalyzed alpha-arylation reaction to form the key carbon-carbon bond and set the absolute and relative stereochemistry.
引用
收藏
页码:4938 / 4941
页数:4
相关论文
共 50 条
  • [21] Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine
    Ho, Tony W.
    Ho, Andrew P.
    Ge, Yang
    Assaid, Christopher
    Gottwald, Regina
    MacGregor, E. Anne
    Mannix, Lisa K.
    van Oosterhout, Willebrordus P. J.
    Koppenhaver, Janelle
    Lines, Christopher
    Ferrari, Michel D.
    Michelson, David
    CEPHALALGIA, 2016, 36 (02) : 148 - 161
  • [22] Examining the binding properties of MK-0974: A CGRP receptor antagonist for the acute treatment of migraine
    Moore, Eric L.
    Burgey, Christopher S.
    Paone, Daniel V.
    Shaw, Anthony W.
    Tang, Yui S.
    Kane, Stefanie A.
    Salvatore, Christopher A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 602 (2-3) : 250 - 254
  • [23] The enantioselective synthesis of tetracyclic methyllycaconitine analogues
    Sparrow, Kevin
    Barker, David
    Brimble, Margaret A.
    TETRAHEDRON, 2011, 67 (41) : 7989 - 7999
  • [24] Formal enantioselective total synthesis of bisdehydroneostemoninine
    Ma, Kai-Qing
    Ren, Hu-Bin
    Chao, Jian-Bin
    Qin, Xue-Mei
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2020, 22 (07) : 655 - 662
  • [25] Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine
    Luo, Guanglin
    Chen, Ling
    Conway, Charles M.
    Denton, Rex
    Keavy, Deborah
    Gulianello, Michael
    Huang, Yanling
    Kostich, Walter
    Lentz, Kimberley A.
    Mercer, Stephen E.
    Schartman, Richard
    Signor, Laura
    Browning, Marc
    Macor, John E.
    Dubowchik, Gene M.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (04): : 337 - 341
  • [26] ROLE OF CALCITONIN GENE-RELATED PEPTIDE (CGRP) RECEPTOR ANTAGONIST IN ACUTE AND PREVENTIVE TREATMENT OF MIGRAINE
    Dacka, Michal
    Sobczyk, Mateusz
    Dabrowska, Paulina
    Gizewska, Kamila
    Zuber, Michal
    PROSPECTS IN PHARMACEUTICAL SCIENCES, 2024, 22 (03): : 21 - 26
  • [27] Efficient and Enantioselective Rhodium(I)-Catalyzed Arylation of α-Ketoesters: Synthesis of (S)-Flutriafol
    Chang, Chiung-An
    Uang, Tsung-Ying
    Jian, Jia-Hong
    Zhou, Meng-Yi
    Chen, Ming-Liang
    Kuo, Ting-Shen
    Wu, Ping-Yu
    Wu, Hsyueh-Liang
    ADVANCED SYNTHESIS & CATALYSIS, 2018, 360 (17) : 3381 - 3390
  • [28] CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured
    Walker, Christopher S.
    Raddant, Ann C.
    Woolley, Michael J.
    Russo, Andrew F.
    Hay, Debbie L.
    CEPHALALGIA, 2018, 38 (03) : 437 - 451
  • [29] Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
    Ho, Tony W.
    Connor, Kathryn M.
    Zhang, Ying
    Pearlman, Eric
    Koppenhaver, Janelle
    Fan, Xiaoyin
    Lines, Christopher
    Edvinsson, Lars
    Goadsby, Peter J.
    Michelson, David
    NEUROLOGY, 2014, 83 (11) : 958 - 966
  • [30] A Scalable Synthesis of CE-157119 HCl Salt, an SRI/5-HT2A Antagonist
    Tao, Yong
    Widlicka, Daniel W.
    Hill, Paul D.
    Couturier, Michel
    Young, Gregory R.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (11) : 1805 - 1810